Dr Steven Russell Hinderer, MD | |
34020 7 Mile Rd Ste 102, Livonia, MI 48152-3093 | |
(734) 622-9500 | |
(734) 622-9555 |
Full Name | Dr Steven Russell Hinderer |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 34020 7 Mile Rd Ste 102, Livonia, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619915782 | NPI | - | NPPES |
4301052044 | Medicaid | MI | |
1801308788 | Other | NPI TYPE 2 |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 4301052044 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Steven Russell Hinderer, MD 7285 W Ellsworth Rd, Ann Arbor, MI 48103-9277 Ph: (734) 622-9500 | Dr Steven Russell Hinderer, MD 34020 7 Mile Rd Ste 102, Livonia, MI 48152-3093 Ph: (734) 622-9500 |
News Archive
Researchers have found a causal link between caesarean section birth, low intestinal microbiota and peanut sensitivity in infants, and they report the effect is more pronounced in children of Asian descent than others, in a recently published paper in the journal of the American Gastroenterological Association.
Cell Therapeutics, Inc. today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for Pixuvriâ„¢ (pixantrone dimaleate) for relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL").
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
GlaxoSmithKline has announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 4 days ago
Jeff Scott Pierce, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 18312 Middlebelt Rd, Livonia, MI 48152 Phone: 248-680-9000 Fax: 248-680-2929 | |
Dr. Ranjini Satyadev, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 14555 Levan Rd., #314, Livonia, MI 48154 Phone: 734-464-4138 Fax: 734-293-5379 | |
Icelle Grace Villanueva Martinez, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 36313 St Andrews Dr, Livonia, MI 48152 Phone: 248-805-2622 | |
Dr. Ayman Tarabishy, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 34020 7 Mile Rd Ste 101, Livonia, MI 48152 Phone: 248-516-5016 Fax: 248-516-5017 | |
Mrs. Urszula Michalski, RPTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 38777 West Six Mile Road, Suite 209 Supplemental Health Care, Livonia, MI 48152 Phone: 734-452-0395 Fax: 734-779-1361 | |
Dr. Arti Patel Amin, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 14555 Levan Rd, Ste 314, Livonia, MI 48154 Phone: 734-542-1970 Fax: 734-293-5379 |